Viewing nowCombinationCITFORGE 5/160 mg (Amlodipine Besilate, Valsartan)
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.

MFDS item code 201802092 · Approved 2018.05.17 · Insurance code 647303360
Treatment of essential hypertension not controlled with monotherapy
This medicine is used for patients with essential hypertension who have difficulty controlling blood pressure with either amlodipine or valsartan alone. It helps to lower blood pressure by dilating blood vessels and reducing cardiovascular burden, thereby effectively improving blood pressure. Thus, it assists in the treatment of essential hypertension.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medication may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg as monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg as monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg as monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required for patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). This medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
The use of this medication is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication should be discontinued immediately upon confirmation of pregnancy, as taking it during the second and third trimesters can cause serious harm to the fetus or newborn. Patients allergic to the main components of this medication or similar drugs should not take it, including women who are pregnant or nursing, patients with severe kidney or liver disease, and those with certain heart conditions. Patients with a deficiency of body fluids or sodium should correct this condition before taking this medication, and if symptoms of hypotension occur during use, they should seek appropriate measures immediately. Patients with high potassium levels in the blood or impaired kidney function should frequently check potassium levels when taking this medication. Patients with vascular problems in the kidneys or those who have recently had a kidney transplant should use this medication with caution due to the risk of worsening kidney function. If symptoms of vascular edema occur while taking this medication, it should be discontinued immediately and not taken again. Patients with heart failure or post-myocardial infarction should periodically monitor kidney function and blood pressure while taking this medication, and those with severe heart failure require special attention. Caution is advised when driving or operating machinery due to dizziness or fatigue that may occur. There may be interactions when taken with other drugs, so caution is advised, especially when taking antihypertensives, potassium supplements, diuretics, NSAIDs, lithium preparations, simvastatin, CYP3A4 inhibitors, etc. Women who are pregnant or may become pregnant should not take this medication, and it is not recommended for nursing mothers. The safety and efficacy in pediatric patients under 18 years of age have not been sufficiently established, so it is not recommended. Taking more than the recommended dose may lead to severe hypotension or heart-related issues, so care should be taken not to exceed the dosage. Regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary during treatment, and if any abnormal symptoms occur, consult a healthcare professional immediately.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, postural dizziness, sensory disturbance, lightheadedness, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, weakness, frequent urination, polyuria, erectile dysfunction, edema, anasarca, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory decrease, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, micturition disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroirritability, sensory decrease, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to protect it from air and moisture. It's important to maintain the storage temperature between 1 degree and 30 degrees Celsius.
Bright yellow oval film-coated tablet
28 tablets/box [14 tablets/PTP x 2], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.